On February 12th, Eevia Health Plc (publ) (“Eevia”) announced that the Company has signed a term sheet agreement with an international partner for a global supply agreement of a nutraceutical ingredient. Additionally, Stein Ulve, CEO of Eevia, has, through a family holding company, subscribed to his pro-rata portion of shares (5,892,334 shares), amounting to SEK 530k, in the ongoing rights issue. Moreover, he has purchased an additional 219,450 shares and 31,350 TO1 warrants outside the market, also through a family holding company.
LÄS MER